From Yahoo Finance: 2025-04-08 18:14:00

Ken Fisher, billionaire investor, focuses on defensive stocks like Johnson & Johnson (NYSE:JNJ). Fisher’s firm, Fisher Asset Management, has a track record of success. Fisher has strong beliefs in capitalism and uses data-driven strategies to spot bargains. He predicts a shift where Europe’s value stocks outperform US growth stocks.

Despite Fisher’s interest in defensive stocks, Johnson & Johnson faces challenges. UBS reaffirmed a Buy rating, citing a strong core business. JNJ pays a quarterly dividend of $1.24 per share with a yield of 3.24%. Trends in new prescriptions bode well, but JNJ faces competition from promising AI stocks for higher returns.

Johnson & Johnson, a healthcare giant, is a top pick for Fisher. While JNJ offers stability and dividends, other AI stocks may provide higher returns in the short term. UBS remains positive on JNJ’s core business despite recent setbacks. Investors should consider the potential of AI stocks for growth opportunities.

Read more: Among Defensive Stocks Billionaire Ken Fisher is Betting On